Low density lipoprotein heterogeneity for risk evaluation of cardiovascular disease;Low density lipoprotein-heterogenität als prognostischer marker kardiovaskulärer erkrankungen

LaboratoriumsMedizin

Volumn 28, Issue 5, 2004, Pages 447-452

  Winkler, Karl ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Atherogenic lipoprotein phenotype (ALP); Coronary artery disease (CAD); Gradient gel electrophoresis (GGE); LDL subfractions; Nuclear magnetic resonance (NMR) method; Preparative ultracentrifugation; Small, dense LDL

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVIEW; RISK ASSESSMENT; ULTRACENTRIFUGATION;

EID: 8444229322     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1515/LabMed.2004.060     Document Type: Review

References (43)

1. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105:310-5.
2. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-53.
3. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. J Am Med Ass 1996;276:882-8.
4. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J Am Med Ass 1996;276:875-81.
5. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997;95:69-75.
6. Berneis K, Krauss R. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43:1363-79.
7. Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictor of cardiovascular disease in women. Circulation 2002; 106:1930-7.
8. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991;32:1741-53.
9. Dejager S, Bruckert E, Chapman MJ. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 1993;34:295-308.
10. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996; 124:261-71.
11. Nordestgaard BG, Nielsen LB. Atherosclerosis and arterial influx of lipoproteins. Curr Opin Lipidol 1994;5:252-7.
12. Campos H, Moye LA, Glasser SP, Stampfer MJ, Sacks FM. Low-density lipoprotein size, pravastatin treatment, and coronary events. J Am Med Ass 2001;286:1468-74.
13. Winkler K, Wetzka B, Hoffmann MM, Friedrich I, Kinner M, Baumstark MW, Zahradnik H-P, Wieland H, März W. Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 2003;88:1162-6.
14. März W, Scharnagl H, Winkler K, Tiran A, Nauck M, Boehm BO, Winkelmann BR. Low Density Lipoprotein Triglycerides Associated with Low Grade Systemic Inflammation, Adhesion Molecules and Angiographic Coronary Disease. (The Ludwigshafen Risk and Cardiovascular Health Study). Circulation (im Druck) 2004.
15. Austin MA, King M-C, Vranizian KM, Krauss RM. Atherogenic Lipoprotein Phenotype: A proposed Genetic Marker for Coronary Heart Disease Risk. Circulation 1990;82:495-506.
16. Vakkilainen J, Makimattila S, Seppala-Lindroos A, Vehkavaara S, Lahdenpera S, Groop PH, Taskinen MR, Yki-Jarvinen H. Endothelial dysfunction in men with small LDL particles. Circulation 2000;102:716-21.
17. Gofman J, Jones H, Blood lipids and human atherosclerosis. Circulation 1950;11:161-78.
18. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
19. Griffin BA. Low-density lipoprotein heterogeneity. Baillieres Clin Endocrinol Metab 1995;9:687-703.
20. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human plasma. J Clin Invest 1955;34:1345-53.
21. Chapman MJ, Goldstein S, Lagrange D, Laplaud PM. A density gradient ultracentrifugal procedure for the isolation of the major lipoproteion classes from human serum. J Lipid Res 1981;22:339-58.
22. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by gradient ultracentrifugation. Atherosclerosis 1990;83:59-67.
23. Baumstark MW, Kreutz W, Berg A, Frey I, Keul J. Structure of human low-density lipoprotein subfractions, determined by X-ray small-angle scattering. Biochim Biophys Acta 1990;1037:48-57.
24. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 1986;128:417-31.
25. Otvos JD, Jeyarajah EJ, Bennett DW. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 1991;37:377-86.
26. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distribution from a single, rapid measurement. Clin Chem 1992;38:1632-8.
27. Austin M, Krauss RM. Genetic control of low-density-lipoprotein subclasses. Lancet 1986;2:592-5.
28. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Adostino RB, Wilson PWF, Schaefer EJ. Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study. Clin Chem 2004;50:1189-200.
29. Otvos JD, Jeyarajah EJ, Cromwell WC. Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 2002;90:22i-29i.
30. Soedamah-Muthu SS, Chang YF, Otvos JD, Evans RW, Orchard TJ. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2003;46:674-82.
31. St. Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM, Depres JP, Lamarche B. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 2001;104:2295-9.
32. LipoScience I. bazbauNMR LipoProfile Test: nuclear resonance imaging lipoprotein coronary heart disease blood test. Raleigh, NC. (Accessed February 20, 2004, at http://www.liposcience.com/www.lipoprofile.com. 2003.
33. Witte DR, Taskinen MR, Perttunen-Nio H, vanTol A, Livingstone S, Colhoun HM. Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis. J Lipid Res 2004;45:1069-76.
34. Lunin VY, Lunina NL, Ritter S, Frey I, Berg A, Diederichs K, Podjarny AD, Urzhumtsev A, Baumstark MW. Low-resolution data analysis for low-density lipoprotein particle. Acta Crystallogr D Biol Crystallogr 2001;57:108-21.
35. Teerlink T, Scheffer PG, Bakker SJ, Heine RJ. Combined data from LDL composition and size measurement are compatible with discoid particle shape. J Lipid Res 2004;45:954-88.
36. Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ. Cryopreservation with sucrose maintains normal physical and biochemical properties of human plasma low density lipoprotein. J Lipid Res 1992;33:1551-61.
37. Skoglund-Andersson C, Tang R, Bond MG, de Faire U, Hamsten A, Karpe F. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. Arterioscler Thromb Vasc Biol 1999;19:2422-30.
38. Baumstark M, Berg A, Halle M, Rensing U, Roskamm H, Keul J. Small dense LDL are a major determinant for the severity of angiographically assessed CAD, even in groups with similar triglyceride levels. Atherosclerosis 1994;109:29-30.
39. Winkler K, Abletshauser C, Hoffmann MM, Friedrich I, Baumstark MW, Wieland H, März W. Effect of fluvastatin slow-release on low-density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of action. J Clin Endocrinol Metab 2002;87:5485-90.
40. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin Resistance and Hyperinsulinemia in Individuals with Small, Dense, Low Density Lipoprotein Particles. J Clin Invest 1993;92:141-6.
41. Austin MA, Edwards KL. Small, dense low density lipoprotein, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr Opin Lipidol 1996;7:167-71.
42. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [see comments]. N Engl J Med 1998;339:229-34.
43. Winkler K, Konrad T, Füllert S, Friedrich I, Destani R, Baumstark MW, Krebs K, Wieland H, März W. Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension. A double-blind, placebo-controlled study. Diabetes Care 2003;26:2588-94.